Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Patient plan: look up a medication list

CYCLOBENZAPRINE HCL

All products: not a benefit

Other products in the same Health Canada class (M03B, M03BX) — coverage varies; not interchangeable

  • Baclofen (Lioresal Intrathecal): general benefit, Not a benefit
  • Tizanidine (Zanaflex): not a benefit
  • Orphenadrine (Norflex): not a benefit

AG-Cyclobenzaprine · DIN 02485419 · 10mg · tablet

Listed, not a benefitMarketed · checked 2026-09-02
StatusListed, not a benefit
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
AG-Cyclobenzaprine · DIN 02485419 Manufacturer: Angita Pharma Inc.; listing date 2020-12-18 Health Canada: Marketed since 2020-12-22 · brand AG-CYCLOBENZAPRINE · ATC M03BX08 CYCLOBENZAPRINE · form Tablet · route Oral · ingredients CYCLOBENZAPRINE HYDROCHLORIDE 10 MG · company Angita pharma inc. · schedule Prescription
Check this DIN again · Health Canada product record

AG-Cyclobenzaprine: Formulary list price not recorded/unit (unit not stated in source; not the patient's cost)

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=97566 · Verify on the e-Formulary ↗ (DIN 02485419)

Source record
DIN 02485419: AG-Cyclobenzaprine Raw flags: notABenefit=Y, sec3=Y Item: 122000005; group id 241; item number 0432; lccId None; manufacturer id ANG Source form: Tab; strength: 10mg Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category Source prices (unrounded): not recorded; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02485419 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=97566
Interchangeable products
Apo-Cyclobenzaprine · DIN 02177145 · not recorded Auro-Cyclobenzaprine · DIN 02348853 · not recorded Cyclobenzaprine · DIN 02287064 · not recorded Cyclobenzaprine · DIN 02424584 · not recorded Flexeril · DIN 00782742 · not recorded Flexeril · DIN 02495422 · not recorded Jamp-Cyclobenzaprine · DIN 02357127 · not recorded PMS-Cyclobenzaprine · DIN 02212048 · not recorded Ratio-Cyclobenzaprine · DIN 02236506 · not recorded Riva-Cyclobenzaprine · DIN 02242079 · not recorded Teva-Cyclobenzaprine HCL · DIN 02080052 · not recorded
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02485419
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Apo-Cyclobenzaprine · DIN 02177145 · 10mg · tablet

Listed, not a benefitMarketed · checked 2026-09-02
StatusListed, not a benefit
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Apo-Cyclobenzaprine · DIN 02177145 Manufacturer: Apotex Inc.; listing date 1996-10-01 Health Canada: Marketed since 2021-06-18 · brand APO-CYCLOBENZAPRINE · ATC M03BX08 CYCLOBENZAPRINE · form Tablet · route Oral · ingredients CYCLOBENZAPRINE HYDROCHLORIDE 10 MG · company Apotex inc · schedule Prescription
Check this DIN again · Health Canada product record

Apo-Cyclobenzaprine: Formulary list price not recorded/unit (unit not stated in source; not the patient's cost)

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=18806 · Verify on the e-Formulary ↗ (DIN 02177145)

Source record
DIN 02177145: Apo-Cyclobenzaprine Raw flags: notABenefit=Y, sec3=Y Item: 122000005; group id 241; item number 0432; lccId None; manufacturer id APX Source form: Tab; strength: 10mg Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category Source prices (unrounded): not recorded; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02177145 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=18806
Interchangeable products
AG-Cyclobenzaprine · DIN 02485419 · not recorded Auro-Cyclobenzaprine · DIN 02348853 · not recorded Cyclobenzaprine · DIN 02287064 · not recorded Cyclobenzaprine · DIN 02424584 · not recorded Flexeril · DIN 00782742 · not recorded Flexeril · DIN 02495422 · not recorded Jamp-Cyclobenzaprine · DIN 02357127 · not recorded PMS-Cyclobenzaprine · DIN 02212048 · not recorded Ratio-Cyclobenzaprine · DIN 02236506 · not recorded Riva-Cyclobenzaprine · DIN 02242079 · not recorded Teva-Cyclobenzaprine HCL · DIN 02080052 · not recorded
Shortage status: resolved shortage (ended 2024-09-26); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02177145
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Auro-Cyclobenzaprine · DIN 02348853 · 10mg · tablet

Listed, not a benefitMarketed · checked 2026-09-02
StatusListed, not a benefit
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Auro-Cyclobenzaprine · DIN 02348853 Manufacturer: Auro Pharma Inc.; listing date 2011-12-15 Health Canada: Marketed since 2011-06-15 · brand AURO-CYCLOBENZAPRINE · ATC M03BX08 CYCLOBENZAPRINE · form Tablet · route Oral · ingredients CYCLOBENZAPRINE HYDROCHLORIDE 10 MG · company Auro pharma inc · schedule Prescription
Check this DIN again · Health Canada product record

Auro-Cyclobenzaprine: Formulary list price not recorded/unit (unit not stated in source; not the patient's cost)

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=83419 · Verify on the e-Formulary ↗ (DIN 02348853)

Source record
DIN 02348853: Auro-Cyclobenzaprine Raw flags: notABenefit=Y, sec3=Y Item: 122000005; group id 241; item number 0432; lccId None; manufacturer id AUR Source form: Tab; strength: 10mg Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category Source prices (unrounded): not recorded; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02348853 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=83419
Interchangeable products
AG-Cyclobenzaprine · DIN 02485419 · not recorded Apo-Cyclobenzaprine · DIN 02177145 · not recorded Cyclobenzaprine · DIN 02287064 · not recorded Cyclobenzaprine · DIN 02424584 · not recorded Flexeril · DIN 00782742 · not recorded Flexeril · DIN 02495422 · not recorded Jamp-Cyclobenzaprine · DIN 02357127 · not recorded PMS-Cyclobenzaprine · DIN 02212048 · not recorded Ratio-Cyclobenzaprine · DIN 02236506 · not recorded Riva-Cyclobenzaprine · DIN 02242079 · not recorded Teva-Cyclobenzaprine HCL · DIN 02080052 · not recorded
Shortage status: resolved shortage (ended 2024-07-16); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02348853
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Cyclobenzaprine · DIN 02287064 · 10mg · tablet

Listed, not a benefitMarketed · checked 2026-09-02
StatusListed, not a benefit
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Cyclobenzaprine · DIN 02287064 Manufacturer: Sanis Health Inc.; listing date 2011-08-04 Health Canada: Marketed since 2026-05-04 · brand CYCLOBENZAPRINE · ATC M03BX08 CYCLOBENZAPRINE · form Tablet · route Oral · ingredients CYCLOBENZAPRINE HYDROCHLORIDE 10 MG · company Sanis health inc · schedule Prescription
Check this DIN again · Health Canada product record

Cyclobenzaprine: Formulary list price not recorded/unit (unit not stated in source; not the patient's cost)

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=77249 · Verify on the e-Formulary ↗ (DIN 02287064)

Source record
DIN 02287064: Cyclobenzaprine Raw flags: notABenefit=Y, sec3=Y Item: 122000005; group id 241; item number 0432; lccId None; manufacturer id SAI Source form: Tab; strength: 10mg Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category Source prices (unrounded): not recorded; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02287064 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=77249
Interchangeable products
AG-Cyclobenzaprine · DIN 02485419 · not recorded Apo-Cyclobenzaprine · DIN 02177145 · not recorded Auro-Cyclobenzaprine · DIN 02348853 · not recorded Cyclobenzaprine · DIN 02424584 · not recorded Flexeril · DIN 00782742 · not recorded Flexeril · DIN 02495422 · not recorded Jamp-Cyclobenzaprine · DIN 02357127 · not recorded PMS-Cyclobenzaprine · DIN 02212048 · not recorded Ratio-Cyclobenzaprine · DIN 02236506 · not recorded Riva-Cyclobenzaprine · DIN 02242079 · not recorded Teva-Cyclobenzaprine HCL · DIN 02080052 · not recorded
Shortage status: resolved shortage (ended 2026-07-06); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02287064
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Cyclobenzaprine · DIN 02424584 · 10mg · tablet

Listed, not a benefitMarketed · checked 2026-09-02
StatusListed, not a benefit
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Cyclobenzaprine · DIN 02424584 Manufacturer: Sivem Pharmaceuticals ULC; listing date 2020-08-28 Health Canada: Marketed since 2014-10-01 · brand CYCLOBENZAPRINE · ATC M03BX08 CYCLOBENZAPRINE · form Tablet · route Oral · ingredients CYCLOBENZAPRINE HYDROCHLORIDE 10 MG · company Sivem pharmaceuticals ulc · schedule Prescription
Check this DIN again · Health Canada product record

Cyclobenzaprine: Formulary list price not recorded/unit (unit not stated in source; not the patient's cost)

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=90926 · Verify on the e-Formulary ↗ (DIN 02424584)

Source record
DIN 02424584: Cyclobenzaprine Raw flags: notABenefit=Y, sec3=Y Item: 122000005; group id 241; item number 0432; lccId None; manufacturer id SIV Source form: Tab; strength: 10mg Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category Source prices (unrounded): not recorded; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02424584 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=90926
Interchangeable products
AG-Cyclobenzaprine · DIN 02485419 · not recorded Apo-Cyclobenzaprine · DIN 02177145 · not recorded Auro-Cyclobenzaprine · DIN 02348853 · not recorded Cyclobenzaprine · DIN 02287064 · not recorded Flexeril · DIN 00782742 · not recorded Flexeril · DIN 02495422 · not recorded Jamp-Cyclobenzaprine · DIN 02357127 · not recorded PMS-Cyclobenzaprine · DIN 02212048 · not recorded Ratio-Cyclobenzaprine · DIN 02236506 · not recorded Riva-Cyclobenzaprine · DIN 02242079 · not recorded Teva-Cyclobenzaprine HCL · DIN 02080052 · not recorded
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02424584
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Jamp-Cyclobenzaprine · DIN 02357127 · 10mg · tablet

Listed, not a benefitMarketed · checked 2026-09-02
StatusListed, not a benefit
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Jamp-Cyclobenzaprine · DIN 02357127 Manufacturer: Jamp Pharma Corporation; listing date 2012-11-27 Health Canada: Marketed since 2019-01-02 · brand JAMP-CYCLOBENZAPRINE · ATC M03BX08 CYCLOBENZAPRINE · form Tablet · route Oral · ingredients CYCLOBENZAPRINE HYDROCHLORIDE 10 MG · company Jamp pharma corporation · schedule Prescription
Check this DIN again · Health Canada product record

Jamp-Cyclobenzaprine: Formulary list price not recorded/unit (unit not stated in source; not the patient's cost)

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=84222 · Verify on the e-Formulary ↗ (DIN 02357127)

Source record
DIN 02357127: Jamp-Cyclobenzaprine Raw flags: notABenefit=Y, sec3=Y Item: 122000005; group id 241; item number 0432; lccId None; manufacturer id JPC Source form: Tab; strength: 10mg Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category Source prices (unrounded): not recorded; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02357127 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=84222
Interchangeable products
AG-Cyclobenzaprine · DIN 02485419 · not recorded Apo-Cyclobenzaprine · DIN 02177145 · not recorded Auro-Cyclobenzaprine · DIN 02348853 · not recorded Cyclobenzaprine · DIN 02287064 · not recorded Cyclobenzaprine · DIN 02424584 · not recorded Flexeril · DIN 00782742 · not recorded Flexeril · DIN 02495422 · not recorded PMS-Cyclobenzaprine · DIN 02212048 · not recorded Ratio-Cyclobenzaprine · DIN 02236506 · not recorded Riva-Cyclobenzaprine · DIN 02242079 · not recorded Teva-Cyclobenzaprine HCL · DIN 02080052 · not recorded
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02357127
Shortage record checked 2026-09-13T08:10:21.292534+00:00

PMS-Cyclobenzaprine · DIN 02212048 · 10mg · tablet

Listed, not a benefitMarketed · checked 2026-09-02
StatusListed, not a benefit
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
PMS-Cyclobenzaprine · DIN 02212048 Manufacturer: Pharmascience Inc.; listing date 1996-12-19 Health Canada: Marketed since 1996-12-31 · brand PMS-CYCLOBENZAPRINE - TAB 10MG · ATC M03BX08 CYCLOBENZAPRINE · form Tablet · route Oral · ingredients CYCLOBENZAPRINE HYDROCHLORIDE 10 MG · company Pharmascience inc · schedule Prescription
Check this DIN again · Health Canada product record

PMS-Cyclobenzaprine: Formulary list price not recorded/unit (unit not stated in source; not the patient's cost)

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=19827 · Verify on the e-Formulary ↗ (DIN 02212048)

Source record
DIN 02212048: PMS-Cyclobenzaprine Raw flags: notABenefit=Y, sec3=Y Item: 122000005; group id 241; item number 0432; lccId None; manufacturer id PMS Source form: Tab; strength: 10mg Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category Source prices (unrounded): not recorded; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02212048 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=19827
Interchangeable products
AG-Cyclobenzaprine · DIN 02485419 · not recorded Apo-Cyclobenzaprine · DIN 02177145 · not recorded Auro-Cyclobenzaprine · DIN 02348853 · not recorded Cyclobenzaprine · DIN 02287064 · not recorded Cyclobenzaprine · DIN 02424584 · not recorded Flexeril · DIN 00782742 · not recorded Flexeril · DIN 02495422 · not recorded Jamp-Cyclobenzaprine · DIN 02357127 · not recorded Ratio-Cyclobenzaprine · DIN 02236506 · not recorded Riva-Cyclobenzaprine · DIN 02242079 · not recorded Teva-Cyclobenzaprine HCL · DIN 02080052 · not recorded
Shortage status: resolved shortage (ended 2024-08-02); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02212048
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Riva-Cyclobenzaprine · DIN 02242079 · 10mg · tablet

Listed, not a benefitMarketed · checked 2026-09-02
StatusListed, not a benefit
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Riva-Cyclobenzaprine · DIN 02242079 Manufacturer: Laboratoire Riva Inc.; listing date 2025-04-30 Health Canada: Marketed since 2018-10-05 · brand RIVA-CYCLOBENZAPRINE · ATC M03BX08 CYCLOBENZAPRINE · form Tablet · route Oral · ingredients CYCLOBENZAPRINE HYDROCHLORIDE 10 MG · company Laboratoire riva inc. · schedule Prescription
Check this DIN again · Health Canada product record

Riva-Cyclobenzaprine: Formulary list price not recorded/unit (unit not stated in source; not the patient's cost)

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=65753 · Verify on the e-Formulary ↗ (DIN 02242079)

Source record
DIN 02242079: Riva-Cyclobenzaprine Raw flags: notABenefit=Y, sec3=Y Item: 122000005; group id 241; item number 0432; lccId None; manufacturer id RIA Source form: Tab; strength: 10mg Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category Source prices (unrounded): not recorded; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02242079 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=65753
Interchangeable products
AG-Cyclobenzaprine · DIN 02485419 · not recorded Apo-Cyclobenzaprine · DIN 02177145 · not recorded Auro-Cyclobenzaprine · DIN 02348853 · not recorded Cyclobenzaprine · DIN 02287064 · not recorded Cyclobenzaprine · DIN 02424584 · not recorded Flexeril · DIN 00782742 · not recorded Flexeril · DIN 02495422 · not recorded Jamp-Cyclobenzaprine · DIN 02357127 · not recorded PMS-Cyclobenzaprine · DIN 02212048 · not recorded Ratio-Cyclobenzaprine · DIN 02236506 · not recorded Teva-Cyclobenzaprine HCL · DIN 02080052 · not recorded
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02242079
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Teva-Cyclobenzaprine HCL · DIN 02080052 · 10mg · tablet

Listed, not a benefitMarketed · checked 2026-09-02
StatusListed, not a benefit
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Teva-Cyclobenzaprine HCL · DIN 02080052 Manufacturer: Teva Canada Limited; listing date 1996-10-01 Health Canada: Marketed since 2016-12-22 · brand TEVA-CYCLOBENZAPRINE · ATC M03BX08 CYCLOBENZAPRINE · form Tablet · route Oral · ingredients CYCLOBENZAPRINE HYDROCHLORIDE 10 MG · company Teva canada limited · schedule Prescription
Check this DIN again · Health Canada product record

Teva-Cyclobenzaprine HCL: Formulary list price not recorded/unit (unit not stated in source; not the patient's cost)

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=15912 · Verify on the e-Formulary ↗ (DIN 02080052)

Source record
DIN 02080052: Teva-Cyclobenzaprine HCL Raw flags: notABenefit=Y, sec3=Y Item: 122000005; group id 241; item number 0432; lccId None; manufacturer id TEV Source form: Tab; strength: 10mg Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category Source prices (unrounded): not recorded; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02080052 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=15912
Interchangeable products
AG-Cyclobenzaprine · DIN 02485419 · not recorded Apo-Cyclobenzaprine · DIN 02177145 · not recorded Auro-Cyclobenzaprine · DIN 02348853 · not recorded Cyclobenzaprine · DIN 02287064 · not recorded Cyclobenzaprine · DIN 02424584 · not recorded Flexeril · DIN 00782742 · not recorded Flexeril · DIN 02495422 · not recorded Jamp-Cyclobenzaprine · DIN 02357127 · not recorded PMS-Cyclobenzaprine · DIN 02212048 · not recorded Ratio-Cyclobenzaprine · DIN 02236506 · not recorded Riva-Cyclobenzaprine · DIN 02242079 · not recorded
Shortage status: resolved shortage (ended 2026-03-04); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02080052
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Flexeril · DIN 02495422 · 10mg · tablet

Listed, not a benefitDormant since 2023-07-05 · checked 2026-09-02 · What does dormant mean?
StatusListed, not a benefit
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Flexeril · DIN 02495422 Manufacturer: Orimed Pharma; listing date 2020-06-30 Health Canada: Dormant since 2023-07-05 · brand FLEXERIL · ATC M03BX08 CYCLOBENZAPRINE · form Tablet · route Oral · ingredients CYCLOBENZAPRINE HYDROCHLORIDE 10 MG · company Orimed pharma inc · schedule Prescription
Check this DIN again · Health Canada product record

Flexeril: Formulary list price not recorded/unit (unit not stated in source; not the patient's cost)

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=98534 · Verify on the e-Formulary ↗ (DIN 02495422)

Source record
DIN 02495422: Flexeril Raw flags: notABenefit=Y, sec3=Y Item: 122000005; group id 241; item number 0432; lccId None; manufacturer id ORI Source form: Tab; strength: 10mg Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category Source prices (unrounded): not recorded; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02495422 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=98534
Interchangeable products
AG-Cyclobenzaprine · DIN 02485419 · not recorded Apo-Cyclobenzaprine · DIN 02177145 · not recorded Auro-Cyclobenzaprine · DIN 02348853 · not recorded Cyclobenzaprine · DIN 02287064 · not recorded Cyclobenzaprine · DIN 02424584 · not recorded Flexeril · DIN 00782742 · not recorded Jamp-Cyclobenzaprine · DIN 02357127 · not recorded PMS-Cyclobenzaprine · DIN 02212048 · not recorded Ratio-Cyclobenzaprine · DIN 02236506 · not recorded Riva-Cyclobenzaprine · DIN 02242079 · not recorded Teva-Cyclobenzaprine HCL · DIN 02080052 · not recorded
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02495422
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Health Canada lists this DIN as Dormant since 2023-07-05 — choose a marketed DIN from the same-category list.

Flexeril · DIN 00782742 · 10mg · tablet

Listed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2005-08-04 — choose a marketed DIN from the same-category list.Discontinued 2005-08-04 · checked 2026-09-02
StatusListed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2005-08-04 — choose a marketed DIN from the same-category list.
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives; Health Canada lists this DIN as Cancelled post market since 2005-08-04 — choose a marketed DIN from the same-category list.
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Flexeril · DIN 00782742 Manufacturer: Merck Frosst Canada & Cie, Merck Frosst Canada & Co.; listing date 1996-10-01 Health Canada: Cancelled post market since 2005-08-04 · brand FLEXERIL -(10MG) · ATC M03BX08 CYCLOBENZAPRINE · form Tablet · route Oral · ingredients CYCLOBENZAPRINE HYDROCHLORIDE 10 MG · company Janssen inc · schedule Prescription
Check this DIN again · Health Canada product record

Flexeril: Formulary list price not recorded/unit (unit not stated in source; not the patient's cost)

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=8605 · Verify on the e-Formulary ↗ (DIN 00782742)

Source record
DIN 00782742: Flexeril Raw flags: notABenefit=Y, sec3=Y Item: 122000005; group id 241; item number 0432; lccId None; manufacturer id FRS Source form: Tab; strength: 10mg Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category Source prices (unrounded): not recorded; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=00782742 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=8605
Interchangeable products
AG-Cyclobenzaprine · DIN 02485419 · not recorded Apo-Cyclobenzaprine · DIN 02177145 · not recorded Auro-Cyclobenzaprine · DIN 02348853 · not recorded Cyclobenzaprine · DIN 02287064 · not recorded Cyclobenzaprine · DIN 02424584 · not recorded Flexeril · DIN 02495422 · not recorded Jamp-Cyclobenzaprine · DIN 02357127 · not recorded PMS-Cyclobenzaprine · DIN 02212048 · not recorded Ratio-Cyclobenzaprine · DIN 02236506 · not recorded Riva-Cyclobenzaprine · DIN 02242079 · not recorded Teva-Cyclobenzaprine HCL · DIN 02080052 · not recorded
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00782742
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Health Canada lists this DIN as Cancelled post market since 2005-08-04 — choose a marketed DIN from the same-category list.

Ratio-Cyclobenzaprine · DIN 02236506 · 10mg · tablet

Listed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2015-10-26 — choose a marketed DIN from the same-category list.Discontinued 2015-10-26 · checked 2026-09-02
StatusListed, not a benefit; Health Canada lists this DIN as Cancelled post market since 2015-10-26 — choose a marketed DIN from the same-category list.
Write on scriptnot a benefit; no Exceptional Access criteria on record; see alternatives; Health Canada lists this DIN as Cancelled post market since 2015-10-26 — choose a marketed DIN from the same-category list.
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Ratio-Cyclobenzaprine · DIN 02236506 Manufacturer: Ratiopharm Inc.; listing date 1999-09-15 Health Canada: Cancelled post market since 2015-10-26 · brand RATIO-CYCLOBENZAPRINE · ATC M03BX08 CYCLOBENZAPRINE · form Tablet · route Oral · ingredients CYCLOBENZAPRINE HYDROCHLORIDE 10 MG · company Ratiopharm inc division of teva canada limited · schedule Prescription
Check this DIN again · Health Canada product record

Ratio-Cyclobenzaprine: Formulary list price not recorded/unit (unit not stated in source; not the patient's cost)

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=59925 · Verify on the e-Formulary ↗ (DIN 02236506)

Source record
DIN 02236506: Ratio-Cyclobenzaprine Raw flags: notABenefit=Y, sec3=Y Item: 122000005; group id 241; item number 0432; lccId None; manufacturer id RPH Source form: Tab; strength: 10mg Recorded listing: Listed, not a benefit; ODB pays only for the benefit products in this interchangeable category Source prices (unrounded): not recorded; ministry not recorded Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02236506 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=59925
Interchangeable products
AG-Cyclobenzaprine · DIN 02485419 · not recorded Apo-Cyclobenzaprine · DIN 02177145 · not recorded Auro-Cyclobenzaprine · DIN 02348853 · not recorded Cyclobenzaprine · DIN 02287064 · not recorded Cyclobenzaprine · DIN 02424584 · not recorded Flexeril · DIN 00782742 · not recorded Flexeril · DIN 02495422 · not recorded Jamp-Cyclobenzaprine · DIN 02357127 · not recorded PMS-Cyclobenzaprine · DIN 02212048 · not recorded Riva-Cyclobenzaprine · DIN 02242079 · not recorded Teva-Cyclobenzaprine HCL · DIN 02080052 · not recorded
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02236506
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Health Canada lists this DIN as Cancelled post market since 2015-10-26 — choose a marketed DIN from the same-category list.
Other drugs in the same formulary class (12:20 Skeletal Muscle Relaxants) and how they are covered

Matched class: 12:20 Skeletal Muscle Relaxants

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Covered without a code on the Ontario formulary: DANTROLENE SODIUM Some products covered without a code (check the product listing): BACLOFEN 12:20 Skeletal Muscle Relaxants

BACLOFEN

· 28 products · Off-Formulary Interchangeable, not an ODB benefit (12), General benefit (16) · strengths: 2mg/mL, 0.05mg/mL, 0.5mg/mL, 10mg, 20mg · Inj Sol (Preservative-Free), Inj Sol-1mL Pk (Preservative-Free), Inj Sol-20mL Pk (Preservative-Free), Tab

TIZANIDINE HCL

· 3 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 4mg · Tab

ORPHENADRINE CITRATE

· 2 products · Listed, not a benefit · strengths: 60mg/2mL · Inj Sol-2mL Pk

DANTROLENE SODIUM

· 1 products · General benefit · strengths: 25mg · Cap Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26; class 12:20
Full class listing Related classes: 12:04 Parasympathomimetic (Cholinergic) Agents, 12:08 Parasympatholytic (Cholinergic Blocking) Agents, 12:12 Sympathomimetic (Adrenergic) Agents Same formulary class, not same indication: class membership alone does not establish equivalent uses.
What the Health Canada label says it is for
1. INDICATIONS Teva-Cyclobenzaprine (cyclobenzaprine hydrochloride) is indicated:  As an adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal conditions. Cyclobenzaprine should be used only for short periods (up to two or three weeks), because adequate evidence of effectiveness for more prolonged use is not available, and because muscle spasm associated with acute, painful musculoskeletal conditions is generally of short duration and specific therapy for longer periods is seldom warranted. Cyclobenzaprine hydrochloride has not been found effective in the treatment of spasticity associated with cerebral or spinal cord disease, or in children with cerebral palsy. 1.1 Pediatrics Pediatrics (< 15 years of age): The safety and effectiveness of cyclobenzaprine hydrochloride in children below 15 years of age have not been established. 1.2 Geriatrics Geriatrics (>65 years of age): Evidence from clinical studies suggests that use in the geriatric population is associated with differences in safety or effectiveness (s ee 4.2 Recommended Dose and Dosage Adjustment, 7.1.4 Geriatrics and 10.3 Pharmacokinetics). https://pdf.hres.ca/dpd_pm/00062662.PDF PM date: Mar 18, 1994 Source product: TEVA-CYCLOBENZAPRINE; DIN 02080052; fetched 2026-09-10 Product monograph posted by Health Canada; excerpt for lookup only.
Health Canada: dormant products
Health Canada defines dormant products as: “products that were previously marketed in Canada but for which the manufacturer has suspended sale for period of at least 12 months.” (canada.ca, Sep 10, 2026 ↗)

Other review policies

For AG-Cyclobenzaprine, Apo-Cyclobenzaprine, Auro-Cyclobenzaprine, Cyclobenzaprine, Jamp-Cyclobenzaprine, PMS-Cyclobenzaprine, Riva-Cyclobenzaprine, Teva-Cyclobenzaprine HCL, Flexeril, Ratio-Cyclobenzaprine: no applicable EAP criteria are held and no ODB benefit is established. These policies do not establish coverage.

For rare, immediately life-, limb- or organ-threatening circumstances, the Compassionate Review Policy may consider an unfunded drug or indication, subject to its criteria and without bypassing the drug review process. Compassionate Review Policy

Compassionate Review Policy: source quote
Where there are rare clinical circumstances in immediately life, limb, or organ-threatening conditions, the Executive Officer will also consider requests for drugs or indications in situations where there has not been a decision by the Executive Officer to provide funding of the drug or indication as part of the Ontario Drug Benefit program (and the EAP), and the drug or indication requested would not circumvent the established review process for new drugs or indications as part of the drug submission process for listing within the Ontario Drug Benefit program. Requests must meet the criteria for the Compassionate Review Policy.

Ontario source; updated September 15, 2026

For cancer drugs, Case-by-Case Review considers rare, immediately life-threatening circumstances when no satisfactory funded treatment exists; its criteria and application process apply. Case-by-Case Review (cancer drugs)

Case-by-Case Review (cancer drugs): source quote
Note: Requests for cancer drugs are considered under the Case-by-Case Review Program (CBCRP) which is administered by Ontario Health (Cancer Care Ontario) on behalf of the Ministry of Health. The CBCRP considers funding requests for drugs (both oral therapies and injectable drugs) for the treatment of cancer in patients who have a rare clinical circumstance that is immediately life-threatening (death is likely within a matter of months) and who require treatment with an unfunded drug, because there is no other satisfactory and funded treatment. Please refer to the Ontario Health website for information on the application process, FAQs, eligibility criteria and program policies.

Ontario source; updated September 15, 2026